Fibroblasts constitute a significant proportion of the stromal compartment in many solid tumors and these infiltrating cells can acquire an activated cancer-associated fibroblast (CAF) phenotype. There is now extensive evidence functionally implicating CAFs in tumor progression via their ability to deposit and remodel extracellular matrix components, secrete pro-tumorigenic factors and modulate the immune compartment.
In breast cancer this so-called ‘desmoplastic response’ shows a clinical correlation with invasion and poor patient prognosis. In addition, there is an increasing body of data supporting a role of CAFs in promoting resistance to chemotherapy and targeted agents.
Despite the growing interest in the functional role of CAFs in tumors, much of their biology remains a mystery because of the lack of specific markers, as well as fibroblast phenotypic plasticity and heterogeneity both in vivo and in vitro.
Together, these have hampered efforts to disentangle the mechanisms underlying tumor:fibroblast crosstalk that could reveal novel strategies for disrupting stromal activation and thereby enhancing therapeutic targeting of tumor cells.
Using in vivo models researchers identify Wnt7a as a key factor secreted exclusively by aggressive breast tumor cells, which induces CAF conversion.
Functionally, this results in extracellular matrix remodelling to create a permissive environment for tumor cell invasion and promotion of distant metastasis.
Mechanistically, Wnt7a-mediated fibroblast activation is not dependent on classical Wnt signalling. Instead, authors demonstrate that Wnt7a potentiates TGFβ receptor signalling both in 3D in vitro and in vivo models, thus highlighting the interaction between two of the key signalling pathways in development and disease.
Importantly, in clinical breast cancer cohorts, tumor cell Wnt7a expression correlates with a desmoplastic, poor-prognosis stroma and poor patient outcome.
http://www.nature.com/ncomms/2016/160118/ncomms10305/full/ncomms10305.html
Tumor:fibroblast crosstalk mechanism to promote cancer aggressiveness
- 1,824 views
- Added
Edited
Latest News
Key mechanism for maintaini…
By newseditor
Posted 06 Jun
How tumor stiffness alters…
By newseditor
Posted 06 Jun
Neural circuit involved in…
By newseditor
Posted 06 Jun
Signaling mechanism in live…
By newseditor
Posted 05 Jun
Statin prevents cancer deve…
By newseditor
Posted 05 Jun
Other Top Stories
Circulating immune cells drawn to the brain during stress can contr…
Read more
Epigenetic dysregulation of immune genes in Alzheimer's
Read more
Faulty DNA disposal system causes inflammation
Read more
B cells teach T cells which targets must not be attacked
Read more
Tubular mitochondria network in Multiple Sclerosis microglia
Read more
Protocols
Clinical and CSF single-cel…
By newseditor
Posted 05 Jun
ChatGPT-assisted deep learn…
By newseditor
Posted 04 Jun
Turning the tide in aggress…
By newseditor
Posted 03 Jun
Mapping medically relevant…
By newseditor
Posted 01 Jun
Accessible high-speed image…
By newseditor
Posted 30 May
Publications
Aggregation-resistant alpha…
By newseditor
Posted 06 Jun
POT1 recruits and regulates…
By newseditor
Posted 06 Jun
Normal or improved cardiova…
By newseditor
Posted 06 Jun
Cytosolic pH is a direct ne…
By newseditor
Posted 06 Jun
Control of feeding by a bot…
By newseditor
Posted 06 Jun
Presentations
Hydrogels in Drug Delivery
By newseditor
Posted 12 Apr
Lipids
By newseditor
Posted 31 Dec
Cell biology of carbohydrat…
By newseditor
Posted 29 Nov
RNA interference (RNAi)
By newseditor
Posted 23 Oct
RNA structure and functions
By newseditor
Posted 19 Oct
Posters
A chemical biology/modular…
By newseditor
Posted 22 Aug
Single-molecule covalent ma…
By newseditor
Posted 04 Jul
ASCO-2020-HEALTH SERVICES R…
By newseditor
Posted 23 Mar
ASCO-2020-HEAD AND NECK CANCER
By newseditor
Posted 23 Mar
ASCO-2020-GENITOURINARY CAN…
By newseditor
Posted 23 Mar